Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
Study Finds on MSN4h
When Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayIn a nutshell Scientists discovered that an enzyme called SSAT1 turns helpful immune cells into harmful ones in psoriasis, ...
A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...
Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...
From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and ...
Scientists have supercharged CAR-T therapy, making it more powerful against elusive cancer cells that usually escape ...
Explore diffuse large B-cell lymphoma — symptoms, causes, diagnosis, treatment options, and prevention. Learn about its types ...
2don MSNOpinion
My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...
Siltuximab effectively treated patients who experienced common adverse events after chimeric antigen receptor T-cell therapy, ...
A recent study on T cell gene therapy trials shows that while secondary malignancies occur in a small percentage of patients, ...
Poor physical function correlated with outcomes among patients with non-Hodgkin lymphoma who underwent chimeric antigen receptor T-cell therapy, according to results of a retrospective cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback